The current kidney care model - focused on late -stage disease and in -centre haemodialysis - is unsustainable, because of costs, environmental burden, poor outcomes, and reduced quality of life. The 78th World Health Assembly ’s recognition of kidney disease as a serious health threat presents a critical opportunity to reshape kidney care. Aligned with this, the 2026 World Kidney Day theme, “Kidney Health for All: Caring for People, Protecting the Planet ”, calls for a systematic change. A sustainable model must prioritise early detection and prevention, reducing the need for kidney replacement therapy. Transplantation and home dialysis benefit people with kidney failure, environment and society. Dialysis itself must become more eco -friendly without compromising care quality, recognising that planetary perturbations in turn affect kidney health. Conservative care should also be considered, particularly for elderly and frail patients, if the quality -of-life benefits outweigh the perspectives offered by dialysis. Achieving this shift requires coordinated action across all stakeholders; education and engagement of the public, policymakers and health professionals to raise awareness about the threat of kidney disease; and an urgent move toward patient -centered care

Early identification of kidney disease can protect kidney health, prevent kidney disease progression and related complications, reduce cardiovascular disease risk and decrease mortality. We must ask “Are your kidneys ok?” using serum creatinine to estimate kidney function and urine albumin to assess for kidney and endothelial damage. Evaluation for causes and risk factors for chronic kidney disease (CKD) includes testing for diabetes and measurement of blood pressure and body mass index. This World Kidney Day, we assert that case -finding in high-risk populations, or even population level screening, can decrease the burden of kidney disease globally. Early -stage CKD is asymptomatic, simple to test for and recent paradigm shifting CKD treatments such as sodium glucose co-transporter -2 inhibitors dramatically improve outcomes and favour the cost -benefit analysis for screening or case -finding programmes. Despite this, numerous barriers exist, including resource allocation, healthcare funding, healthcare infrastructure and healthcare -professional and population awareness of kidney disease. Coordinated efforts by major kidney non -governmental organisations to prioritise the kidney health agenda for governments and aligning early detection efforts with other current programmes will maximise efficiencies.